Skip to content
Screener

Bruker BRKR Operating Income

Operating Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.09B
Danaher logo
DanaherDHR
$1.13B+48.3%
TEC
Bio-TechneTECH
$75.5M+95.0%
WAT
Waters CorporationWAT
-$86M-146%
Agilent Technologies logo
Agilent TechnologiesA
$399M+33.0%
908 Devices logo
908 DevicesMASS
-$12.88M-16.9%

Segments

By segment

See full
Adjustments And Reconciling Items$183.9M
Bsi Calid$72.3M+35.6%
Bsi Biospin$41.7M+80.5%
Bsi Nano$29.8M+217%
Energy And Supercon Technologies$7.6M+5.6%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Goodwill impairment charge134.9134.9
Other charges, net13.214.439.451.3
Total operating expenses481.3346.0850.9705.4
Operating (loss) income(65.3)11.9(55.1)43.7
Interest and other income (expense), net24.6(11.4)36.3(18.1)
(Loss) income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries(40.7)0.5(18.8)25.6
Income tax provision (benefit)14.2(3.1)16.75.6
Equity in income of unconsolidated investees, net of tax4.00.60.31.0

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's operating income?
Bruker (BRKR) reported operating income of -$65.3M in Q2 2026.
How has Bruker's operating income changed year-over-year?
Bruker's operating income decreased by 648.7% year-over-year, from $11.9M to -$65.3M.
What is the long-term trend for Bruker's operating income?
Over 4 years (2021 to 2025), Bruker's operating income has grown at a -36.3% compound annual growth rate (CAGR), from $413.3M to $68.2M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Bruker's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude